{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:04:47Z","timestamp":1784531087149,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["1095RA210084"],"award-info":[{"award-number":["1095RA210084"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["W81XWH-22-1-1095 RA210084"],"award-info":[{"award-number":["W81XWH-22-1-1095 RA210084"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA259243"],"award-info":[{"award-number":["R21CA259243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA265827"],"award-info":[{"award-number":["R01CA265827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA256419"],"award-info":[{"award-number":["R21CA256419"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020984","name":"Cedars Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119654","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:40:31Z","timestamp":1781541631000},"page":"119654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Linker-dependent variations in the tumoricidal activity of DZ-1\u2013dihydroartemisinin conjugate formats"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6467-9095","authenticated-orcid":false,"given":"Farzaneh","family":"Vafaeinik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9164-0459","authenticated-orcid":false,"given":"Sarah","family":"Helmueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-9397","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heuiran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-4281","authenticated-orcid":false,"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-6075","authenticated-orcid":false,"given":"Robert","family":"Figlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Sargsyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-8489","authenticated-orcid":false,"given":"Yong J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119654_bib1","unstructured":"National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology: Colon Cancer (Version 1.2026). \u3008https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1428\u3009."},{"issue":"6","key":"10.1016\/j.biopha.2026.119654_bib2","first-page":"409","article-title":"Advances in systemic therapy for colorectal cancer","volume":"20","author":"Grothey","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119654_bib3","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, N.S. Wagle, A. Jemal, 2023, Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17-48. https:\/\/doi.org\/10.3322\/caac.21763.","DOI":"10.3322\/caac.21763"},{"issue":"23","key":"10.1016\/j.biopha.2026.119654_bib4","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"New. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.biopha.2026.119654_bib5","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for the treatment of metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119654_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119654_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2026.119654_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fob.2012.05.002","article-title":"Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity","volume":"2","author":"Wang","year":"2012","journal-title":"FEBS Open. Bio"},{"issue":"10","key":"10.1016\/j.biopha.2026.119654_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: Their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","journal-title":"Cell. Death & Differ."},{"issue":"11","key":"10.1016\/j.biopha.2026.119654_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119654_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fphar.2020.00444","article-title":"Iron promotes dihydroartemisinin cytotoxicity via ROS production and blockade of autophagic flux via lysosomal damage in osteosarcoma","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119654_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: More ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119654_bib14","first-page":"1009","article-title":"Artemisinin derivatives: An updated patent review (2015-2020)","volume":"31","author":"Li","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. & Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Investig. New. Drugs"},{"key":"10.1016\/j.biopha.2026.119654_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fncel.2017.00310","article-title":"Dihydroartemisinin exerts anti-tumor activity by inducing mitochondrion and endoplasmic reticulum apoptosis and autophagic cell death in human glioblastoma cells","volume":"11","author":"Qu","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2026.119654_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib19","first-page":"19","article-title":"Artemisinin and its synthetic derivatives as a possible therapy for cancer","volume":"6","author":"Konstat-Korzenny","year":"2018","journal-title":"Med. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119654_bib20","first-page":"379","article-title":"Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate-induced apoptosis","volume":"26","author":"Jiang","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119654_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CAD.0b013e32834f6ea8","article-title":"Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes","volume":"23","author":"Tin","year":"2012","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00280-009-1129-z","article-title":"Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro","volume":"66","author":"Zhou","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119654_bib23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3892\/or.2013.2494","article-title":"Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells","volume":"30","author":"Lim","year":"2013","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119654_bib24","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/1078-0432.CCR-10-0059","article-title":"Near IR heptamethine cyanine dye-mediated cancer imaging","volume":"16","author":"Yang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119654_bib25","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.21.5.050901","article-title":"Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy","volume":"21","author":"Shi","year":"2016","journal-title":"J. Biomed. Opt."},{"issue":"13","key":"10.1016\/j.biopha.2026.119654_bib26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.32033","article-title":"Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate","volume":"125","author":"Mrdenovic","year":"2019","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2026.119654_bib27","article-title":"Novel DZ-SIM conjugate targets cancer mitochondria and prolongs survival in pancreatic ductal adenocarcinoma","volume":"5","author":"Ou","year":"2022","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119654_bib28","first-page":"535","article-title":"Role of organic anion-transporting polypeptides (OATPs) in cancer therapy","volume":"15","author":"Thakkar","year":"2013","journal-title":"AAPS J."},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119654_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/mp3005353","article-title":"A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells","volume":"10","author":"Thakkar","year":"2013","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119654_bib31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bcp.2013.07.020","article-title":"Role of hypoxia inducible factor-1\u03b1 in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer","volume":"86","author":"Han","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119654_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biopha.2026.119654_bib33","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119654_bib34","doi-asserted-by":"crossref","DOI":"10.34133\/2021\/9769347","article-title":"A computational comparison of ether and ester electrolyte stability on a Ca metal anode","volume":"2021","author":"Liepinya","year":"2021","journal-title":"Energy Mater. Adv."},{"issue":"4","key":"10.1016\/j.biopha.2026.119654_bib35","first-page":"285","article-title":"Carbamate group as structural motif in drugs: A review of carbamate derivatives used as therapeutic agents","volume":"71","author":"Mato\u0161evi\u0107","year":"2020","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"10.1016\/j.biopha.2026.119654_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114481","article-title":"Low extracellular pH enhances TRAIL-induced apoptosis by downregulating Mcl-1 expression","volume":"447","author":"Vafaeinik","year":"2025","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.biopha.2026.119654_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.880878","article-title":"NOX4 mediates epithelial cell death in hyperoxic acute lung injury through mitochondrial reactive oxygen species","volume":"13","author":"Harijith","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119654_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/metabo13070796","article-title":"Cancer metabolism: The role of ROS in DNA damage and induction of apoptosis in cancer cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.biopha.2026.119654_bib39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/cb500078u","article-title":"Bright building blocks for chemical biology","volume":"9","author":"Lavis","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","article-title":"Acid suspends the circadian clock in hypoxia through inhibition of mTOR","volume":"174","author":"Walton","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119654_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2025.101586","article-title":"Surface modified CaO nanoparticles with CMC\/D-carvone for enhanced anticancer, antimicrobial and antioxidant activities","volume":"102","author":"Suresh","year":"2025","journal-title":"J. Indian. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119654_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.113213","article-title":"Nanostructured ZnCo\u2082S\u2084@metal organic frameworks composite for supercapacitor by ultrasonication supported hydrothermal reaction","volume":"170","author":"Indumathi","year":"2024","journal-title":"Inorg. Chem. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00449-024-03097-y","article-title":"Efficient one-pot green synthesis of carboxymethyl cellulose\/folic acid embedded ultrafine CeO\u2082 nanocomposite and its superior multi-drug resistant antibacterial activity and anticancer activity","volume":"48","author":"Boopathi","year":"2025","journal-title":"Bioprocess. Biosyst. Eng."},{"issue":"13","key":"10.1016\/j.biopha.2026.119654_bib44","doi-asserted-by":"crossref","first-page":"18324","DOI":"10.1016\/j.ceramint.2022.03.091","article-title":"Green synthesized zinc oxide nanoparticles: Effect of polyethylene glycol and chitosan on structural, optical and morphological analysis","volume":"48","author":"Al-Ghamdi","year":"2022","journal-title":"Ceram. Int."},{"key":"10.1016\/j.biopha.2026.119654_bib45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119654_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-409X(01)00125-9","article-title":"Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells","volume":"49","author":"Modica-Napolitano","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"24","key":"10.1016\/j.biopha.2026.119654_bib47","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1073\/pnas.0912925107","article-title":"Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol","volume":"107","author":"Richardson","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5684","key":"10.1016\/j.biopha.2026.119654_bib48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119654_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: Recent insights","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann. New. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119654_bib50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:30:26Z","timestamp":1784529026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0753332226006906"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119654","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linker-dependent variations in the tumoricidal activity of DZ-1\u2013dihydroartemisinin conjugate formats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119654"}}